Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Petco Health and Wellness Company, Inc. filings document the formal disclosures of a pet specialty retailer with Class A common stock listed on Nasdaq under WOOF. Its Form 8-K reports cover operating results, earnings presentations, Regulation FD updates, fiscal outlooks and material events tied to the company's retail, services and digital pet-care business.
Petco's regulatory record also includes capital-structure disclosures for credit agreement amendments, term loan refinancing, senior secured notes due 2031, subsidiary guarantees and collateral priorities. Governance filings document board leadership changes and related compensatory arrangements, while exhibit filings preserve press releases, agreements and other materials incorporated into the company's public record.
May Holly reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. granted equity awards to Chief Human Resources Officer Holly May. She received 201,582 restricted stock units on February 17, 2026 under the 2021 Equity Incentive Plan, each representing one share of Class A common stock or its cash value.
The RSUs vest over three years, with 34% after one year and four additional 16.5% installments through the third anniversary of the grant date. She was also granted 132,296 target performance stock units, which can pay out between 0% and 200% of target based on a performance period ending February 3, 2029 and continued employment through vesting.
Venezia Patrick J reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that Chief Revenue Officer Patrick J. Venezia received equity awards in the form of restricted and performance stock units. He was granted 355,732 restricted stock units under the 2021 Equity Incentive Plan on February 17, 2026, each representing one share of Class A common stock or its cash value. These RSUs vest over three years, with 34% after one year and the remaining portions vesting at 18, 24, 30, and 36 months.
Venezia was also granted 233,464 target performance stock units under the same plan. These PSUs can ultimately result in 0% to 200% of the target number of shares, depending on performance over a period ending on February 3, 2029, based on the company’s 20-day volume weighted average trading price and continued employment through vesting.
Romanko Michael reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that Michael Romanko received sizable equity awards under the company’s 2021 Equity Incentive Plan on February 17, 2026. He was granted 711,463 restricted stock units (RSUs), each representing one share of Class A common stock or its cash value.
The RSUs vest over three years, with 34% on the first anniversary of the grant date and four additional tranches of 16.5% through the third anniversary. Romanko also received 466,927 target performance stock units (PSUs), which can pay out from 0% to 200% of the target based on a performance period ending February 3, 2029 and the company’s 20-day volume-weighted average trading price, subject to continued employment.
SIMMONS SABRINA reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. granted Chief Financial Officer Sabrina Simmons 592,886 restricted stock units (RSUs) and 389,106 performance stock units (PSUs) on February 17, 2026 under its 2021 Equity Incentive Plan.
Each RSU represents one share of Class A common stock or its cash value and will vest in stages over three years: 34% after one year, then 16.5% at 18 months, two years, 30 months, and three years. The PSUs represent a target that can pay out from 0% to 200% of 389,106 shares based on Petco’s 20-day volume-weighted average trading price over a performance period ending February 3, 2029, and require continued employment through the vesting date.
Insana Giovanni reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that executive Giovanni Insana received equity awards consisting of 189,724 restricted stock units and 124,514 performance stock units under the company’s 2021 Equity Incentive Plan. These awards were granted at a price of $0.00 per unit as part of compensation.
The RSUs vest in stages from the first through the third anniversary of the February 17, 2026 grant date, with 34% vesting after one year and the remaining portions vesting at 18, 24, 30 and 36 months. Each RSU represents one share of Class A common stock or its cash value.
The PSU grant reflects a target of 124,514 units, with the actual number of shares earned ranging from 0% to 200% of target. The final payout will be determined after a performance period ending on February 3, 2029, based on Petco’s 20-day volume-weighted average trading price and continued employment through vesting.
Petco Health & Wellness Company, Inc. Chief Executive Officer and director Joel D. Anderson reported acquiring 5,000 shares of Class A common stock on January 30, 2026 at $2.29 per share under the company’s 2021 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Following this purchase, he beneficially owned 3,231,281 Class A shares directly, which include 2,466,451 restricted stock units where each unit represents one share. He also reported indirect holdings of 853,304 shares by a 2020 Trust, 229,204 shares by a 2025 Trust, 7,874 shares by his son, and 495,706 shares by a Revocable Trust.
Petco Health and Wellness Company, Inc. appointed Glenn Murphy, previously Executive Chairman, as non-employee Chairman of the Board effective February 1, 2026. This change shifts his role from an executive position to an independent board leadership capacity.
In connection with the transition, Mr. Murphy will receive a lump sum payment of $9,615.38 as statutory pay under his May 13, 2024 offer letter and remains eligible for an annual bonus for fiscal 2025, payable when executive officer bonuses are paid. Petco also issued a press release on February 2, 2026 to publicly announce his appointment as Chairman.
Petco Health and Wellness Company, Inc. entered into a Second Amendment to its First Lien Credit Agreement on February 2, 2026. New refinancing term loans of $900 million, together with cash and $600 million of 8.250% senior secured notes due 2031, will repay the existing term loan facility.
The refinancing term loans bear interest at Term Benchmark plus 4.25%, or at the Company’s option Base Rate plus 3.25%, include a 1.00% soft call premium on certain repricings within six months, amortize 1.00% per year, and mature five years after the amendment date. The 8.250% notes carry restrictive covenants and can be redeemed early at specified prices, including a make-whole premium before February 1, 2028.
Petco Health and Wellness Company, Inc. is issuing $600 million of 8.250% senior secured notes due 2031. The company expects the sale of these notes to close on February 2, 2026, subject to customary closing conditions.
The notes will be guaranteed by subsidiaries that already guarantee Petco’s credit facilities. They will be secured with first-lien priority on fixed assets and second-lien priority on current assets, and will sit at different levels of priority versus other existing secured and unsecured debt depending on collateral and lien ranking.
Petco plans to use the net proceeds from the notes, together with borrowings under a new term loan facility and cash on hand, to fully repay its existing term loan facility, cover related fees and expenses, and for general corporate purposes. The company announced these financing plans through a press release furnished as an exhibit.
Petco Health and Wellness Company, Inc. plans to raise $650 million through an offering of senior secured notes due 2031. These notes will be guaranteed by subsidiaries that already guarantee the company’s credit facilities and will be secured by first-lien interests on fixed assets and second-lien interests on current assets.
The company intends to use the net proceeds from the notes, together with borrowings under a new term loan facility and cash on hand, to repay its existing term loan facility in full, cover related fees and expenses, and support general corporate purposes.